Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Receivables (2016 - 2025)

Historic Receivables for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $8.3 million.

  • Rockwell Medical's Receivables fell 627.95% to $8.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year decrease of 627.95%. This contributed to the annual value of $8.3 million for FY2024, which is 2394.28% down from last year.
  • Latest data reveals that Rockwell Medical reported Receivables of $8.3 million as of Q3 2025, which was down 627.95% from $8.1 million recorded in Q2 2025.
  • Rockwell Medical's Receivables' 5-year high stood at $16.2 million during Q2 2022, with a 5-year trough of $5.4 million in Q2 2023.
  • Over the past 5 years, Rockwell Medical's median Receivables value was $10.7 million (recorded in 2021), while the average stood at $10.3 million.
  • Per our database at Business Quant, Rockwell Medical's Receivables tumbled by 6655.75% in 2023 and then surged by 10033.27% in 2024.
  • Over the past 5 years, Rockwell Medical's Receivables (Quarter) stood at $11.8 million in 2021, then tumbled by 47.07% to $6.3 million in 2022, then surged by 74.17% to $10.9 million in 2023, then fell by 23.94% to $8.3 million in 2024, then grew by 0.45% to $8.3 million in 2025.
  • Its last three reported values are $8.3 million in Q3 2025, $8.1 million for Q2 2025, and $9.7 million during Q1 2025.